Hooman Hakami

Chairman of the Board

Hooman is Chairman of the Board and served as Interim Chief Executive Officer of Quanta from July to November 2022. In addition, he is board member and co-founder of Forte Health Advisors, a company that enables innovators to transform healthcare.

With 30 years of business leadership experience, Hooman has been a corporate officer at 2 of the largest companies in the world—Medtronic and GE. As a member of Medtronic’s executive committee and group president for diabetes, Hooman grew the Diabetes Group to approximately $2.5 billion, launched a transformational new product, and drove market share to record levels. Prior to Medtronic, he was president of GE’s detection & guidance solutions business, a $2 billion group within GE Healthcare that encompassed the full suite of X-ray products in the portfolio.

In addition to Quanta, Hooman serves on the board of 3 private companies: Mpirik, an AI company whose algorithms enable comprehensive cardiac disease detection across a hospital’s entire cardiology department; PathMaker Neurosystems, the only multisite, noninvasive neuromodulation company that is focused on the treatment of complications associated with neurodegenerative disease; and GCX, the global leader in the design and manufacturing of healthcare-focused, mission-critical equipment mounting and mobility solutions.

Over his career, Hooman has amassed a 360-degree view of healthcare—from capital equipment, consumer devices, and technology-enabled services to extensive experience dealing with providers, commercial payers, governments, and patients.